Results 141 to 150 of about 2,041 (194)

Across ancestries, HLA-B∗08:01∼DRB1∗03:01 (DR3) and HLA-DQA∗01:02 (DR2) increase the risk to develop juvenile-onset systemic lupus erythematosus through low complement C4 levels. [PDF]

J Transl Autoimmun
Renaudineau Y, Charras A, Natoli V, Congy-Jolivet N, Haldenby S, Liu X, Fang Y, Smith EM, Beresford MW, Hedrich CM, UK jSLE Cohort Study Group.   +10 more
europepmc   +1 more source

Epidemiologi ved juvenil systemisk lupus erythematosus (JSLE)

Norsk Epidemiologi, 2008
Odd Vinje, Berit Flatø
openaire   +1 more source

Bacterial infection in patients with juvenile systemic lupus erythematosus and fever. [PDF]

Pediatr Rheumatol Online J
Gómez-Urrego JF, Yepes-Madrid N, Gil-Artunduaga MA, Del Pilar Gómez-Mora M, Mejía-Rivera LF, Pacheco-López R, Rojas-Hernández JP.   +6 more
europepmc   +1 more source

CAR-T cell therapy for juvenile-onset autoimmune diseases: a promising future? [PDF]

Arthritis Res Ther
Jouret M, Viel S, Fournier B, Benezech S, Avouac J, Scherlinger M, Belot A, C3I consortium.   +7 more
europepmc   +1 more source

Vaccinations in Paediatric Rheumatology: an Update on Current Developments [PDF]

, 2015

core   +1 more source

CVD-risk assessment in JSLE

, 2023
openaire   +1 more source

Case Report: Diagnostic itinerary of a male case of juvenile-onset systemic lupus erythematosus in Bouake. [PDF]

Front Pediatr
Traore AD, Koffi JKE, Koffi CZRM, Yao KJC, Goua JJ, Kouakou ESC, Tia WM, Daboiko FJC.   +7 more
europepmc   +1 more source

Aveu et Dénombrement : La Seigneurie de Vaudreuil (1725) [PDF]

, 1949
Groulx, Lionel
core   +1 more source

Validation of childhood lupus specific targets: ensuring accurate assessment of disease control in younger, lighter paediatric patients. [PDF]

Rheumatology (Oxford)
Sarker C, Jorgensen AL, Tharmaratnam K, Al-Abadi E, Armon K, Bailey K, Bohm M, Brennan M, Ciurtin C, Gardner-Medwin J, Hawley DP, Kinder A, Leahy A, Malik G, McLaren Z, Moraitis E, Mosley E, Ramanan AV, Rangaraj S, Ratcliffe A, Riley P, Rostron H, Sen ES, Hedrich CM, Beresford MW, Smith EMD.   +25 more
europepmc   +1 more source

Targeting interferon responses in juvenile dermatomyositis: Siglec-1 as an in vitro biomarker for JAK inhibitor efficacy. [PDF]

Rheumatology (Oxford)
Veldkamp SR, Reugebrink M, Evers SW, Moreau TRJ, Bondet V, Armbrust W, van den Berg JM, Hissink Muller PCE, Kamphuis S, Schatorjé E, Delemarre EM, van der Kooi AJ, Bader-Meunier B, Duffy D, Rodero MP, Raaphorst J, van Royen-Kerkhof A, Jansen MHA, van Wijk F.   +18 more
europepmc   +1 more source